Shire Investor Relations
Here we provide key financial data and company information of value to an analyst, shareholder or potential investor.
Proposed acquisition of NPS Pharma
Research and Development day
December 10, 2014 - We provide an update to the investment community on the Company’s R&D pipeline, which is focused on innovative medicines to treat rare diseases and other specialty conditions.
Download the App
Financial results and reports at your fingertips.